ProZIB validation -- Tosoian (Partin tables)
Research authors: None
Details
Download

Discrimination

Rows included 656
C-index 0.69 | 95% CI: 0.6467 - 0.7312 ROC
Brier score Not specified
Scaled Brier score Not specified

Classification plot

Not specified

Calibration

Regression coefficient 0.95
Intercept 0.15
Hosmer-Lemeshow GOF Not specified
 

Calibration plot

Histogram

Not specified

Decision curve

Not specified
Comparison
Original study population: 4459
Validation study population: 0

Categorical characteristics

Name Subset / Group Nr. of patients Validation P-Value
Race White 3505 Not available
African american 587
Hispanic 81
Asian 64
Other 221
PSA Groups (ng/ml) 0-2.5 760 Not available
2.6-4.0 680
4.1-6.0 1584
6.1-10.0 1038
>10.0 397
Biopsy gleason score ≤6 2112 Not available
3 + 4 = 7 1336
4 + 3 = 7 564
8 256
9-10 191
Clinical stage (AJCC-TNM 2002) T1c 3514 Not available
T2a 651
T2b 243
T2c 51
Prostatectomy gleason score ≤6 1617 Not available
3 + 4 1687
4 + 3 664
8 211
9-10 271
Cancer state Organ confined 3278 Not available
Extraprostatic Extension (SV-, LN-) 898
Seminal Vesicle involvement (LN-) 182
Lymph node involvement 101

Continuous characteristics

Name Mean SD Unit Plot
Original Validation Age 59.5
7.0
years
Original Validation PSA 5.7
5.1
ng/ml
Comments
Comment
Please enter a comment
Comments are visible to anyone

Model feedback

No feedback yet 1 Comment {{ comments.length }} Comments
On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
{{ comment.content }}
Evidencio v3.25 © 2015 - 2024 Evidencio. All Rights Reserved